Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice

Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances

(2016) Meena Asmar et al.   Current Opinion in Endocrinology Diabetes and Obesity

Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice

(2012) Nigel Irwin et al.   BIOCHEMICAL PHARMACOLOGY

Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes

(2012) N. Irwin et al.   DIABETOLOGIA

Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes

(2012) N Irwin et al.   INTERNATIONAL JOURNAL OF OBESITY

Metabolic effects of activation of CCK receptor signaling pathways by twice-daily administration of the enzyme-resistant CCK-8 analog, (pGlu-Gln)-CCK-8, in normal mice

(2012) Nigel Irwin et al.   JOURNAL OF ENDOCRINOLOGY

Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms

(2011) Jingchuan Zhang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

CCK Stimulation of GLP-1 Neurons Involves α 1 -Adrenoceptor–Mediated Increase in Glutamatergic Synaptic Inputs

(2011) Kazunari Hisadome et al.   DIABETES

Impaired Insulin Secretion and Enhanced Insulin Sensitivity in Cholecystokinin-Deficient Mice

(2011) C.-M. Lo et al.   DIABETES

The future of incretin-based therapy: novel avenues-novel targets

(2011) B. Ahrén   DIABETES OBESITY & METABOLISM

Sub-chronic administration of stable GIP analog in mice decreases serum LPL activity and body weight

(2011) Ewa Szalowska et al.   PEPTIDES

Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties

(2009) Barry D. Kerr et al.   BIOCHEMICAL PHARMACOLOGY

C-terminal mini-PEGylation of glucose-dependent insulinotropic polypeptide exhibits metabolic stability and improved glucose homeostasis in dietary-induced diabetes

(2008) Victor A. Gault et al.   BIOCHEMICAL PHARMACOLOGY

Antidiabetic effects of sub-chronic activation of the GIP receptor alone and in combination with background exendin-4 therapy in high fat fed mice

(2008) Nigel Irwin et al.   REGULATORY PEPTIDES

PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement

(2007) I Verbaeys et al.   BRITISH JOURNAL OF PHARMACOLOGY